×

Patrys Limited

Patrys is a Melbourne based publicly-listed company on the Australian Securities Exchange (ASX:PAB).  The company’s focus is the commercialisation of novel antibody therapeutics for oncology.

Despite recent advances, new therapies are desperately needed to help fight a range of cancers.  Patrys is committed to the development and commercialisation of novel antibody technologies and aims to revolutionise patient outcomes across a range of hard-to-treat cancers.  Patrys is focussed on initially targeting underserved oncology indications, such as glioblastoma and metastatic triple-negative breast cancer, with the potential of expanding to other indications

Spotlight Videos